Adjuvant radiation, chemotherapy, andandrogen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate

Boring, 1993, Cancer statistics, Ca Cancer J Clin, 43, 7, 10.3322/canjclin.43.1.7 Donohue, 1990, Intraoperative and early complications staging pelvic lymph node dissection in prostatic adenocarcinorna, Urology, 35, 223, 10.1016/0090-4295(90)80036-M Stamey, 1989, Prostate specific antigen in the ddiagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients, J Urol, 141, 1076, 10.1016/S0022-5347(17)41175-X Parin, 1990, Prostate specific antigen in the staging of localized prostate cancer: influence of tumor, differentiation, tumor volume and benign hyperplasia, J Urol, 143, 747, 10.1016/S0022-5347(17)40079-6 Byar, 1988, Hormone therapy for prostate cancer: results of the Veteran's Administration Cooperative Urological Research Group studies, NCI Monogr, 7, 165 Bagshaw, 1985, Potential for radiotherapy alone in prostatic cancer, Cancer, 55, 2079, 10.1002/1097-0142(19850501)55:9+<2079::AID-CNCR2820551408>3.0.CO;2-X Paulson, 1982, Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma, J Urol, 127, 935, 10.1016/S0022-5347(17)54136-1 Steinberg, 1990, Management of stage Dl adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987, J Urol, 144, 1425, 10.1016/S0022-5347(17)39759-8 Zincke, 1990, Combined surgery and immediate adjuvant hormonal treatment of stage Dl adenocarcinoma of the prostate: Mayo Clinic experience, Semin Urol, 8, 175 Stein, 1990, Adjuvant endocrine therapy after radical prostatectomy for stage D1 prostate carcinoma, Semin Urol, 8, 184 Zincke, 1989, Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate: significant influences of immediate adjuvant hormonal treatment(orchiectomy) on outcome, Urology, 33, 27, 10.1016/0090-4295(89)90103-9 Carter, 1989, Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy, J Urol, 142, 1266, 10.1016/S0022-5347(17)39052-3 Freeman, 1993, Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PCNO) prostate cancer 1976 to 1989: intermediate findings, J Urol, 149, 1029, 10.1016/S0022-5347(17)36288-2 1992, 183 Gaynor, 1993, On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data, J Am Stat Assoc, 88, 400, 10.2307/2290318 US National Center for Health Statistics: Vital Statisticsof the U.S.-1986. DHHS Publication PHS 88-1122. Ederer, 1961, The relative survival rate: a statistical methodology, NCI Monogr, 6, 101 van den Ouden, 1993, Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression, J Urol, 150, 400, 10.1016/S0022-5347(17)35493-9 Cheng, 1993, Stage Dl. prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy, Cancer, 71, 996, 10.1002/1097-0142(19930201)71:3+<996::AID-CNCR2820711417>3.0.CO;2-8 deVere White, 1983, Adjuvant chemotherapy for Stage Dl adenocarcinoma of prostate, Urology, 21, 270, 10.1016/0090-4295(83)90085-7 Eisenberger, 1988, Chemotherapy for prostate carcinoma, NCI Monogr, 7, 151